Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medopred 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Tablets are white, round, flat, scored tablets, 7 mm diameter. |
Each tablet contains prednisolone 5 mg.
Excipient with known effect: lactose monohydrate.
Each Medopred tablet contains 105.0mg mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Prednisolone |
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Tablets are packed in blisters of polyvinylchloride film and aluminium foil. Packs containing 50, 100, 500 or 1000 tablets, with a patient information leaflet are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
11559
Date of first authorisation: 23/11/1987
Date of Renewal: 30/11/2010
| Drug | Countries | |
|---|---|---|
| MEDOPRED | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
